To the best of our knowledge this is the first trial which has examined the effects of biological interaction between VDR genetic polymorphisms and vitamin D intake on the diverse aspects of responses in breast cancer patients including inflammatory and immune biomarkers as well as those associated with cell proliferation, differentiation, damage and metastasis. This evidence concerns the gene VDR and breast carcinoma.